Next Article in Journal
Metabolomics Fingerprint Induced by the Intranigral Inoculation of Exogenous Human Alpha-Synuclein Oligomers in a Rat Model of Parkinson’s Disease
Next Article in Special Issue
The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance
Previous Article in Journal
Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Extracellular Matrix Remodeling during Left Ventricular Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
Previous Article in Special Issue
mRNA Post-Transcriptional Regulation by AU-Rich Element-Binding Proteins in Liver Inflammation and Cancer
 
 
Review
Peer-Review Record

Tumor Infiltrating Regulatory T Cells in Sporadic and Colitis-Associated Colorectal Cancer: The Red Little Riding Hood and the Wolf

Int. J. Mol. Sci. 2020, 21(18), 6744; https://doi.org/10.3390/ijms21186744
by Massimo Claudio Fantini 1,*, Agnese Favale 1, Sara Onali 2 and Federica Facciotti 3
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2020, 21(18), 6744; https://doi.org/10.3390/ijms21186744
Submission received: 27 August 2020 / Revised: 11 September 2020 / Accepted: 11 September 2020 / Published: 14 September 2020

Round 1

Reviewer 1 Report

This is excellent review article titled "Tumor infiltrating Tregs in sporadic and colitis associated colorectal cancer: the red little riding hood or the wolf? " on the role of regulatory T cells (Tregs) in colorectal cancer and colitis-related CRC. I am fully supportive of its publication. A couple of minor suggestions:

  1. in the title, change Tregs to the full name. 
  2. Discuss Tregs in the CRCs with mis-matched DNA repair gene deficiency, related to Lynch Syndrome or sporadic mutation of methylation of the gene promoter that result in the absence of expression of the mis-matched repair gene products leading to microsatellite instability, since this condition renders the CRC to be sensitive to immune checkpoint inhibitors. 
  3. Discuss how co-stimulation with CD28 and CTLA regulate Tregs and CD4/CD8 T cells, for readers to understand more clearly the mechanisms that underlie the regulation of T cells by co-stimulation. 

Thanks. 

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

  1. The title of the manuscript as a question is unclear.
  2. Please insert one or two sentences of conclusion at the end of the abstract.
  3. Lack of the list of abbreviations, or every abbreviation and it’s full name should be given at first time in the text.
  4. The clear description of all figure should be given, especially Figure 1.
  5. The figure No. 2 is not clear and readable, please improve it.
  6. The table is required at the end of Chapter 3:

    molecule/ basic mechanism of action / target cells / number of references

  1. Separate chapter describing the role and importance of Tregs in the course of inflammatory bowel inflammation is very necessary.
  2. Please insert another chapters numbering:

    4. Sporadic and colitis-associated colorectal cancer

   4.1 Tregs in sporadic CRC

   4.2 Tregs in colitis associated colorectal cancer

  1. Manipulation of Tregs for the therapy of CRC
  2. Summary

    9. The conclusion concern with particular chapter should be given at the end of chapter 4.1 and 4.2.

   10. Expression “CRC and CAC” is not correct, should be used “sporadic CRC and CAC”, because CRC does mean  whole cancer group.  

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Back to TopTop